Yes, Platinum controls Implant's future. I do believe Platinum is close to selling the company for the reasons I mentioned previously. As to the amount, I didn't run an exacting spread sheet to come up with a number, like $100 million or 25 cents or whatever. I shouldn't have even suggested a number, because my point wasn't to be that specific. My point is, the numbers board members expect/hope for are so out of line as to be illogical, even absurd. The stock is in the mid-50 cent range at the moment, meaning the market values the company at $100 million, or 2x assumed FY16 revenue of $50 million. I find that rich, but not absurd. What I find absurd is Perry's estimate of $550 million, which is 11x revenue. Even 4x, which values the company at $200 million, is far beyond what I believe is reasonable to expect, given Smiths paid 2x revenue for Morpho. But we shall see. For myself, I somehow found myself in a food fight debating numbers with board participants when all I wanted to do is give a heads up as I saw it. The debate is over. I may make one more contribution to the board detailing the legal problems that have engulfed Platinum Partners, but that's it. I think we're all comfortable with our respective positions. We'll know very soon who was right.
